Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The 2nd PP

<< Previous

Bullboard Posts

Next >>

Comment by Infinityon Oct 06, 2022 1:00pm

210 Views

Post# 35009833

RE:RE:RE:RE:RE:The 2nd PP

Fecat, Not sure where you are quoting. Pls read the Sedar filing. The exact wording is "Securities issued in the financing are subect to a statutory hold period of four months". Both stock and the warrant are tradeable in 4 months.

<< Previous

Bullboard Posts

Next >>

Understanding Implied Volatility in Options Trading